tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Stock Investors

Compare
131 Followers
Based on 802,393 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PHAR
On average, investors allocate 0.00% of their portfolios to PHAR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 802,393 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PHAR

4.7%
Last 7
Days
1.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PHAR, out of 802,393 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PHAR Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$7.98
Based on the activity of investors who made their portfolios public
The table shows changes in PHAR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PHAR Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
4.27%
+0.45%
+3.86%
30.52B
Consumer Cyclical
Viking Therapeutics
3.77%
-0.03%
-4.67%
2.99B
Healthcare
CVS Health
3.97%
-0.28%
-2.96%
80.44B
Healthcare
Lucid Group
5.19%
+0.04%
-0.52%
6.68B
Consumer Cyclical
Nio
8.11%
-0.38%
-4.88%
7.28B
Consumer Cyclical
Riot Platforms
4.48%
-0.80%
-3.55%
3.23B
Financial
Marathon Digital Holdings
4.88%
-0.55%
-3.61%
5.40B
Financial
Delta Air Lines
4.53%
-0.64%
-3.57%
31.88B
Industrials
Rivian Automotive
5.63%
-0.97%
-4.59%
16.47B
Consumer Cyclical
Bristol-Myers Squibb
3.09%
-0.26%
-2.69%
97.87B
Healthcare
Based on the activity of 802,393 active portfolios
Open your Smart Portfolio

PHAR Investor Analysis

PHAR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.0%
of PHAR holders
are under 35
Average Segment Performance
Average P/E Ratio10.99
Beta4.52
Dividend Yield4.11%
PHAR investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
70.0%
of PHAR holders
are between 35–55
Average Segment Performance
Average P/E Ratio5.01
Beta11.31
Dividend Yield3.48%
PHAR investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of PHAR holders
are over 55
Average Segment Performance
Average P/E Ratio1.85
Beta4.79
Dividend Yield3.82%
Overview of age group and performance of PHAR stock investors
See who invests in PHAR according to age group and performance.

FAQ

How many retail Investors hold PHAR?
<0.1% of TipRanks' retail investors hold PHAR in their portfolios.
    What is PHAR Investor Sentiment?
    PHAR’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of PHAR in the last 7 days?
      ▲ 4.7% of TipRanks' retail investors changed their holding of PHAR in the last 7 days.
        What percentage of retail investors changed their holding of PHAR in the last 30 days?
        ▼ 1.2% of TipRanks' retail investors changed their holding of PHAR in the last 30 days.
          What is the average age of retail investors who hold PHAR?
          The average age of PHAR Holders is between 35–55.
            What other stocks have PHAR investors also bought?
            PHAR Investors also bought DKNG, VKTX, CVS, LCID, NIO, RIOT, MARA, DAL, RIVN, BMY.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis